Joby Aviation stock falls after $500M defense acquisition
Joby Aviation shares fell about 6% after it agreed to buy Resonant Sciences for about $500M, according to Investing.com. Resonant reported over $100M trailing-twelve-month revenue and high-teens adjusted EBITDA margins. Joby plans to fund with ~$450M cash and ~$50M in JOBY stock; closing is expected in 1H 2027, subject to approvals.
How this was made
The 30-second read
Why it matters
The transaction changes Joby’s segment mix and introduces deal-execution and regulatory-review risk, while also adding revenue growth and backlog momentum from Resonant.
Market read
A definitive $500M M&A deal with a cash-and-stock funding structure is driving an immediate repricing in JOBY shares.
What to watch
Key sensitivities are regulatory review timing, integration execution, and whether the $50M stock component implies dilution at an unfavorable price versus alternative financing.
Background
Joby is expanding beyond its commercial electric air taxi focus by adding a dedicated defense business unit through the Resonant Sciences acquisition.
Ticker impact
Joby shares fell 6% after announcing a definitive agreement to acquire Resonant Sciences for about $500 million.
Near-term downside bias likely persists until deal terms, regulatory path, and integration milestones become clearer.
The article provides a concrete, time-bound M&A disclosure ($500M price, $450M cash plus $50M stock, close in 1H 2027) and ties it to an immediate 6% drop, implying the market is repricing risk and/or dilution expectations.
Market effects
Highlights continued consolidation and defense-adjacent expansion among eVTOL and aerospace suppliers, potentially raising deal premium expectations for similar assets.
Concentrates manufacturing and integration footprint in Dayton, Ohio, which may matter for local industrial and defense supply-chain sentiment.
US national security procurement and RF/mission-systems demand remains a tailwind theme, but the impact is primarily company-specific via the acquisition.
Counterpoint
The market selloff may over-discount the long-dated close; Resonant’s revenue growth, backlog doubling, and high-teens adjusted EBITDA margins could support a longer-term earnings contribution.
Key entities
- companyJoby Aviation
NYSE-listed eVTOL company announcing a $500M acquisition of Resonant Sciences.
- companyResonant Sciences
Dayton, Ohio defense technology company providing RF, sensing, and mission systems; expected to become Joby’s dedicated defense unit.
